ATA110696A - METHOD FOR OBTAINING AND PURIFYING RECOMBINANT, NON-LIPIDED OSP PROTEIN - Google Patents

METHOD FOR OBTAINING AND PURIFYING RECOMBINANT, NON-LIPIDED OSP PROTEIN

Info

Publication number
ATA110696A
ATA110696A AT0110696A AT110696A ATA110696A AT A110696 A ATA110696 A AT A110696A AT 0110696 A AT0110696 A AT 0110696A AT 110696 A AT110696 A AT 110696A AT A110696 A ATA110696 A AT A110696A
Authority
AT
Austria
Prior art keywords
lipided
obtaining
purifying recombinant
osp protein
osp
Prior art date
Application number
AT0110696A
Other languages
German (de)
Other versions
AT405940B (en
Inventor
Artur Dr Mitterer
Christa Dr Tauer
Ian Dr Livey
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to AT0110696A priority Critical patent/AT405940B/en
Priority to CZ984253A priority patent/CZ425398A3/en
Priority to JP10501944A priority patent/JP2000516444A/en
Priority to PCT/AT1997/000136 priority patent/WO1997049812A2/en
Priority to EP97926912A priority patent/EP0973909A2/en
Priority to CA002259636A priority patent/CA2259636A1/en
Priority to NO985902A priority patent/NO985902L/en
Publication of ATA110696A publication Critical patent/ATA110696A/en
Application granted granted Critical
Publication of AT405940B publication Critical patent/AT405940B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT0110696A 1996-06-21 1996-06-21 METHOD FOR OBTAINING AND PURIFYING RECOMBINANT, NON-LIPIDED OSP PROTEIN AT405940B (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT0110696A AT405940B (en) 1996-06-21 1996-06-21 METHOD FOR OBTAINING AND PURIFYING RECOMBINANT, NON-LIPIDED OSP PROTEIN
CZ984253A CZ425398A3 (en) 1996-06-21 1997-06-19 Process for preparing and purifying recombinant, non-lipidic osp protein
JP10501944A JP2000516444A (en) 1996-06-21 1997-06-19 Method for recovering and purifying recombinant non-lipidated Osp protein
PCT/AT1997/000136 WO1997049812A2 (en) 1996-06-21 1997-06-19 Process for extracting and purifying recombinant, non-lipidised osp-protein
EP97926912A EP0973909A2 (en) 1996-06-21 1997-06-19 Process for extracting and purifying recombinant, non-lipidised osp-protein
CA002259636A CA2259636A1 (en) 1996-06-21 1997-06-19 Process for extracting and purifying recombinant, non-lipidised osp-protein
NO985902A NO985902L (en) 1996-06-21 1998-12-16 Process for extracting and purifying recombinant, non-lipidized Osp protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0110696A AT405940B (en) 1996-06-21 1996-06-21 METHOD FOR OBTAINING AND PURIFYING RECOMBINANT, NON-LIPIDED OSP PROTEIN

Publications (2)

Publication Number Publication Date
ATA110696A true ATA110696A (en) 1999-05-15
AT405940B AT405940B (en) 1999-12-27

Family

ID=3506722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0110696A AT405940B (en) 1996-06-21 1996-06-21 METHOD FOR OBTAINING AND PURIFYING RECOMBINANT, NON-LIPIDED OSP PROTEIN

Country Status (7)

Country Link
EP (1) EP0973909A2 (en)
JP (1) JP2000516444A (en)
AT (1) AT405940B (en)
CA (1) CA2259636A1 (en)
CZ (1) CZ425398A3 (en)
NO (1) NO985902L (en)
WO (1) WO1997049812A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1645283A1 (en) * 2004-10-08 2006-04-12 Chiron Behring GmbH & Co. KG Combination vaccine
PL2199303T3 (en) 2008-12-12 2013-11-29 Euroimmun Medizinische Labordiagnostika Ag Polypeptides and method for specific metering of antibodies for patients with a borrelia infection
CN114295745B (en) * 2021-12-23 2023-09-08 辽宁成大生物股份有限公司 Method for detecting dimethyl sulfoxide residue in varicella attenuated live vaccine
CN115267027B (en) * 2022-08-29 2023-05-02 上海市精神卫生中心（上海市心理咨询培训中心） Kit and detection method for detecting psychotropic drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI955150A7 (en) * 1993-04-29 1995-12-28 Baxter Ag Immunogenic formulations of OspC antigen vaccines for the prevention and treatment of Lyme disease and recombinant methods for the production of antigens
US5620862A (en) * 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease

Also Published As

Publication number Publication date
EP0973909A2 (en) 2000-01-26
CA2259636A1 (en) 1997-12-31
JP2000516444A (en) 2000-12-12
NO985902D0 (en) 1998-12-16
WO1997049812A3 (en) 1999-11-04
NO985902L (en) 1999-02-19
WO1997049812A2 (en) 1997-12-31
AT405940B (en) 1999-12-27
CZ425398A3 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
DE69814199D1 (en) Method and system for entering characters
DE69707849D1 (en) METHOD FOR PURIFYING 1,4-BUTANDIOL
DE69706430D1 (en) METHOD FOR SEQUENCING DNA
DE69812693D1 (en) METHOD FOR OLIGOMERIZING ISOBUTEN
DE69816789D1 (en) METHOD AND SYSTEM FOR GESTURE-CONTROLLED OPTION SELECTION
DE69824312D1 (en) METHOD AND DEVICE FOR TERMINATING TACHYARRHYTHMIA
DE69819332D1 (en) IMPROVED ANTIBODIES AGAINST IgE AND METHOD FOR IMPROVING ANTIBODIES
DE59703453D1 (en) METHOD FOR REDUCING NITROGEN OXIDES
DE69433934D1 (en) Methods and compositions for increased protein production from recombinant DNA
DE69828571D1 (en) Blood filter set and associated method for obtaining blood components
DE69739854D1 (en) SYSTEM AND METHOD FOR DETERMINING VOLTAGES
DE69734782D1 (en) METHOD AND DEVICE FOR DECODING MULTI-CHANNEL AUDIODATES
DE69715424D1 (en) METHOD FOR HALOGENING ISOOLEFIN-PARA-ALKYLSTYROL COPOLYMERS
DE69732153D1 (en) Method and device for decoding block codes
DE69719409T2 (en) Procedure for purifying DNA
DE69715234D1 (en) METHOD FOR PURIFYING 1,1-DIFLUORETHANE
DE69529052D1 (en) SYSTEM FOR DETECTING MISIGNALS AND METHOD WITH IMPROVED SIGNALABILITY
ATE220558T1 (en) IMPROVED METHOD FOR STABILIZING PROTEINS
DE69728802D1 (en) Particle-immobilized particles and method for protein purification
DE69710078D1 (en) METHOD FOR PURIFYING 1,1,1,3,3-PENTAFLUORPROPANE
EP0781142A4 (en) COMPOSITIONS AND METHOD FOR PROVIDING POLYPEPTIDES
DE69830556D1 (en) Method for the determination of glycosylated proteins
DE69711852D1 (en) FASTENED SiC CUBES AND METHOD FOR FIXING SiC CUBES
DE69719404D1 (en) Method and system for recognizing pointers
ATE240324T1 (en) IMPROVED METHOD FOR PRODUCING THIAZOLIDINDIONES AND NEW THIAZOLIDINDIONES

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee